|Bid||0.1100 x 0|
|Ask||0.1550 x 0|
|Day's Range||0.1450 - 0.1450|
|52 Week Range||0.0650 - 0.4500|
|Beta (5Y Monthly)||-0.30|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") wishes to announces that it has entered into debt settlement agreements with directors and officers to settle debt in the amount of $94,750 by the issuance of 1,263,333 common shares at a deemed price of $0.075 per share. The shares will be subject to a four month hold period from the ...
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2020) - Veritas Pharma Inc.'s (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") is pleased to announce that on May 14th, 2020, the company entered into a Letter of Intent ("LOI") to acquire Indigenous Bloom Hemp Corporation ("HempCo").HempCo operates a large-scale industrial hemp farm in Southern Manitoba on approximately 347 acres of zoned farmland. The primary business of the Company is sale of hemp ...